London, United Kingdom
Medbelle, established in 2016, operates at the intersection of Health Care and Information Technology, with a mission to elevate the quality of healthcare and make it universally accessible. Headquartered in the United Kingdom, the company focuses on integrating patient-centric care with advanced technology to ensure a seamless, personalized healthcare experience.
The startup last secured a significant $7.00M Series A investment on 15 April 2019. This funding round attracted a broad spectrum of investors, including Cavalry Ventures, Signals Venture Capital, IBB Ventures, Marbruck Investments, Talis Capital, Mavericks Founders, Warrick Shanly, and Mutschler Ventures AG. This backing highlights a strong vote of confidence from distinguished VCs and strategic partners aligned with Medbelle's vision.
Medbelle’s approach to revolutionizing healthcare presents a compelling opportunity for investors interested in the rapidly evolving health-tech landscape, characterized by a clear commitment to improving patient outcomes through digital innovation.
